Browse
Submit Data
Databases
API
Help

Dataset Information

14 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bupropion hydro-bromide propanol hemisolvate.

ABSTRACT: The title compound {systematic name: N-[1-(3-chloro-phen-yl)-1-oxopropan-2-yl]-tert-butanaminium bromide propanol hemisolvate}, C(13)H(19)ClNO(+)·Br(-)·0.5C(3)H(8)O, crystallizes with two independent bupropion hydro-bromide ion pairs and a solvent 1-propanol mol-ecule in the asymmetric unit. In both mol-ecules, the expected proton transfer from HBr to the amino group of the bupropion mol-ecule is observed, and intra- and inter-molecular N-H?Br hydrogen-bond inter-actions are formed. These inter-actions link the mol-ecules into hydrogen-bond dimers. The side chains of the two cations have slightly different orientations. The 1-propanol solvent mol-ecule is linked to a bromide ion by an O-H?Br hydrogen bond.

SUBMITTER: Liu M

PROVIDER: S-EPMC3201450 | biostudies-literature | 2011 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Bupropion hydro-bromide propanol hemisolvate.

Liu Min M Hu Xiu-Rong XR Gu Jian-Ming JM Tang Gu-Ping GP

Acta crystallographica. Section E, Structure reports online 20110930 Pt 10

The title compound {systematic name: N-[1-(3-chloro-phen-yl)-1-oxopropan-2-yl]-tert-butanaminium bromide propanol hemisolvate}, C(13)H(19)ClNO(+)·Br(-)·0.5C(3)H(8)O, crystallizes with two independent bupropion hydro-bromide ion pairs and a solvent 1-propanol mol-ecule in the asymmetric unit. In both mol-ecules, the expected proton transfer from HBr to the amino group of the bupropion mol-ecule is observed, and intra- and inter-molecular N-H⋯Br hydrogen-bond inter-actions are formed. These inter- ...[more]

PMID: 22064727

Similar Datasets

Darifenacin hydro-bromide.

Project description:In the title compound {systematic name: (S)-3-[(aminocar-bonyl)diphenylmethyl]-1-[2-(2,3-di-hy-dro-benzofuran-5-yl)ethyl]pyrrolidinium bromide}, C(28)H(31)N(2)O(2) (+)·Br(-), the pyrrolidine rings adopts an envelope conformation. The two phenyl rings make a dihedral angle of 72.5?(1)°. The four coplanar atoms of the pyrrolidine ring makes dihedral angles of 33.1?(2) and 82.8?(2)° with the two phenyl rings. The mol-ecular conformation is influenced by a C-H?O inter-action. In the crystal packing, there are two N-H?Br hydrogen bonds running in opposite directions. They appear to form C(10) and C(9) chain motifs in the unit cell. In addition, the mol-ecular packing is further stabilized by C-H?Br and C-H?O hydrogen bonds. The C atom bonded to the benzofuran ring system is disordered in a 0.66:0.34 ratio.

| S-EPMC2969553 | biostudies-literature

Tri-phenyl-telluronium(IV) bromide acetone hemisolvate.

Project description:The asymmetric unit of the title compound, 2C18H15Te(+)·2Br(-)·C3H6O or Ph3TeBr·0.5Me2CO, contains two crystallographically independent tri-phenyl-telluronium cations, two bromide anions, and one disordered [site-occupancy ratio = 0.581?(7):0.419?(7)] solvent mol-ecule. Inter-ionic Te?Br inter-actions connect the cations and anions into a tetra-meric step-like structure. The primary coordination spheres of both Te atoms are TeC3 trigonal pyramids: three short secondary tellurium-bromine inter-actions expand the coordination geometry of one of the Te atoms to an octa-hedron. While the other Te atom shows only two Te?Br secondary bonding inter-actions, it is also six-coordinated due to a Te?? inter-action [3.769?(2)?Å] with one of the phenyl rings of the adjacent cation.

| S-EPMC3884325 | biostudies-literature

Redetermination of l-tryptophan hydro-bromide.

Project description:The redetermined crystal structure of the title compound, C(11)H(13)N(2)O(2) (+)·Br(-), is reported. Data collection at 100?K about three crystallographic axes resulted in a crystal structure with significantly higher precision in comparison to the two-dimensional data collected at 176?K [Takigawa et al. [(1966) Bull. Chem. Soc. Jpn, 39, 2369-2378]. The carboxyl group and indole ring system are planar, with maximum deviations of 0.002?(2) and 0.007?(2)?Å, respectively, and make an angle of 70.17?(1)° with each other. The mol-ecules are arranged in double layers of carboxyl and amino groups parallel to the ab plane, stabilized by an extensive network of N-H?Br and O-H?Br hydrogen bonds. The polar layer is held together by a network of three N-H?Br hydrogen bonds and one O-H?Br hydrogen bond. In the non-polar layer, the indole rings are linked mainly by electrostatic N-H?C inter-actions between the polarized bond N-H (H is ?(+)) of the pyrrole unit and two of the ring C atoms (?(-)) of the benzene rings of adjacent mol-ecules. The distances of these electrostatic inter-actions are 2.57 and 2.68?Å, respectively. C-H?O and C-H?? inter-actions are also present.

| S-EPMC2969532 | biostudies-literature

(S)-2-Oxotetra-hydro-furan-3-aminium bromide.

Project description:In the title HBr salt of (S)-homoserine lactone, C(4)H(8)NO(2) (+)·Br(-), the five-membered ring has an envelope conformation, with the -CH(2)- C atom adjacent to the N-substituted C atom at the flap position. The four-atom mean plane (r.m.s. deviation = 0.005 Å) of the envelope forms a dihedral angle of 32.12 (9)° with the three-atom flap plane. The distorted square-pyramidal coordination about the anion involves five surrounding cations, with the square base defined by three N-H⋯Br hydrogen bonds [Br⋯N = 3.3046 (10), 3.3407 (12) and 3.3644 (13) Å] and near-contact with an H atom attached to C [Br⋯C = 3.739 (1) Å]. Another Br⋯C contact of 3.427 (1) Å defines the apex. There is also an N-H⋯O hydrogen bond present linking the cations.

| S-EPMC3414985 | biostudies-literature

[Tris(3,5-diphenyl-pyrazol-yl)hydro-borato]nickel(II) bromide.

Project description:In the title tris-(pyrazol-yl)borate (Tp(Ph2)) complex, [NiBr(C(45)H(34)BN(6))], the Ni, Br and B atoms lie on a crystallographic threefold axis and a distorted NiN(3)Br tetra-hedral geometry arises for the metal ion. In the crystal, C-H?(C=C) and C-H?? inter-actions help to establish the polar crystal packing.

| S-EPMC2969450 | biostudies-literature

Tris(4-formyl-phen-yl)phosphane oxide tetra-hydro-furan hemisolvate.

Project description:The title compound, C21H15O4P·0.5C4H8O, contains an ordered phosphane oxide in a general position and a tetra-hydro-furan solvent mol-ecule disordered about a twofold axis. All three aldehyde substituents are nearly coplanar with their attached benzene rings, with C-C-C-O torsion angles in the range 1.64?(17)-4.24?(19)°. All three have different conformations with respect to the P=O group, one syn, one anti, and one gauche. Two of the aldehyde substituents form inter-molecular C-H?O contacts.

| S-EPMC3793837 | biostudies-other

1-Benzyl-2-dimethyl-amino-3-methyl-3,4,5,6-tetra-hydro-pyrimidin-1-ium bromide.

Project description:In the title molecular salt, C(14)H(22)N(3) (+)·Br(-), the ring incorporating the guanidinium grouping exhibits a half-chair conformation and the dihedral angle between the N-C-N and C-C-C planes is 55.0?(3)°. The C-N bond lengths in the central CN(3) unit are 1.333?(4), 1.338?(3) and 1.341?(4)?Å, indicating partial double-bond character. The central C atom is bonded to the three N atoms in a nearly ideal trigonal-planar geometry and the positive charge is delocalized in the CN(3) plane. The distances between the N atom and the terminal methyl C atoms [1.453?(4)-1.461?(4)?Å] are all close to a typical single C-N bond length.

| S-EPMC3414178 | biostudies-literature

Crystal structure of 2,6-bis-(2-hy-droxy-5-methyl-phen-yl)-4-phenyl-pyridinium bromide di-chloro-methane hemisolvate hemihydrate.

Project description:The asymmetric unit in the structure of the title compound, C25H22NO2 (+)·Br (-)·0.5CH2Cl2·0.5H2O, comprises two pseudosymmetry-related cations, two bromide anions, a di-chloro-methane molecule and a water mol-ecule of solvation. The two independent cations are conformationally similar with the comparative dihedral angles between the central pyridine ring and the three benzene substituent rings being 3.0?(2), 36.4?(1) and 24.2?(1)°, and 3.7?(2), 36.5?(1) and 24.8?(1)°, respectively. In the crystal, the cations, anions and water mol-ecules are linked through O-H?O and O-H?Br hydrogen bonds, forming an insular unit. Within the cations there are also intra-molecular N-H?O hydrogen bonds. Adjacent centrosymmetrically related aggregates are linked by ?-? stacking inter-actions between the pyridine ring and a benzene ring in both cations [ring-centroid separations = 3.525?(3) and 3.668?(3)?Å], forming chains extending across the ac diagonal. Voids between these chains are filled by dichloromethane molecules.

| S-EPMC4719919 | biostudies-literature

Naltrexone/bupropion: Contrave(R); naltrexone SR/bupropion SR.

Project description:In March 2010, Orexigen(R) Therapeutics submitted a new drug application (NDA) for approval of naltrexone sustained release (SR)/bupropion SR (Contrave(R)) for the treatment of obesity in the US. The tablet contains naltrexone SR 32 mg and bupropion SR 360 mg. The drug has been tested in four randomized, double-blind, placebo-controlled, phase III trials and the co-primary endpoints were met in each case. This review discusses the key development milestones and clinical trial program to date.

| S-EPMC3586099 | biostudies-literature

Steviamine, a new class of indolizidine alkaloid [(1R,2S,3R,5R,8aR)-3-hydroxy-meth-yl-5-methyl-octa-hydro-indolizine-1,2-diol hydro-bromide].

Project description:X-ray crystallographic analysis of the title hydro-bromide salt, C(10)H(20)N(+)·Br(-), of (1R,2S,3R,5R,8aR)-3-hydroxy-meth-yl-5-methyl-octa-hydro-indolizine-1,2-diol defines the absolute and relative stereochemistry at the five chiral centres in steviamine, a new class of polyhydroxy-lated indolizidine alkaloid isolated from Stevia rebaudiana (Asteraceae) leaves. In the crystal structure, mol-ecules are linked by inter-molecular O-H?Br and N-H?Br hydrogen bonds, forming double chains around the twofold screw axes along the b-axis direction. Intra-molecular O-H?O inter-actions occur.

| S-EPMC2971327 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data